- Daxor reported new clinical data comparing capillary leak detection scores with direct albumin escape measurement using its Blood Volume Analyzer, and the results were presented at the SCCM 2026 Critical Care Congress.
- The study assessed the relationship between four clinical indices and the Albumin Escape Rate $(AER)$ measured by the device in a heart failure cohort.
- Researchers reported a median AER of 20% per hour despite clinical scores described as uniformly low.
- Clinical indices showed weak and non-significant correlations with measured albumin escape in this dataset.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Daxor Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603260800PRIMZONEFULLFEED9678861) on March 26, 2026, and is solely responsible for the information contained therein.